| Literature DB >> 29212041 |
M Gordon Joyce1, Ivelin S Georgiev1, Yongping Yang1, Aliaksandr Druz1, Hui Geng1, Gwo-Yu Chuang1, Young Do Kwon1, Marie Pancera1, Reda Rawi1, Mallika Sastry1, Guillaume B E Stewart-Jones1, Angela Zheng1, Tongqing Zhou1, Misook Choe1, Joseph G Van Galen1, Rita E Chen1, Christopher R Lees1, Sandeep Narpala1, Michael Chambers1, Yaroslav Tsybovsky2, Ulrich Baxa2, Adrian B McDermott1, John R Mascola3, Peter D Kwong4.
Abstract
The elicitation of autologous neutralizing responses by immunization with HIV-1 envelope (Env) trimers conformationally stabilized in a prefusion closed state has generated considerable interest in the HIV-1 vaccine field. However, soluble prefusion closed Env trimers have been produced from only a handful of HIV-1 strains, limiting their utility as vaccine antigens and B cell probes. Here, we report the engineering from 81 HIV-1 strains of soluble, fully cleaved, prefusion Env trimers with appropriate antigenicity. We used a 96-well expression-screening format to assess the ability of artificial disulfides and Ile559Pro substitution (DS-SOSIP) to produce soluble cleaved-Env trimers; from 180 Env strains, 20 yielded prefusion closed trimers. We also created chimeras, by utilizing structure-based design to incorporate select regions from the well-behaved BG505 strain; from 180 Env strains, 78 DS-SOSIP-stabilized chimeras, including 61 additional strains, yielded prefusion closed trimers. Structure-based design thus enables the production of prefusion closed HIV-1-Env trimers from dozens of diverse strains. Published by Elsevier Inc.Entities:
Keywords: HIV-1 vaccine; conformational stabilization; envelope trimer; prefusion closed trimer; structure-based design
Mesh:
Substances:
Year: 2017 PMID: 29212041 DOI: 10.1016/j.celrep.2017.11.016
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423